Linked Life Data

20881647

Source:http://linkedlifedata.com/resource/pubmed/id/20881647

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20881647rdf:typepubmed:Citationlld:pubmed
pubmed-article:20881647lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C1518578lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C0013072lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C0796392lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C0079083lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C0456599lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C0210657lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C1696465lld:lifeskim
pubmed-article:20881647lifeskim:mentionsumls-concept:C1327830lld:lifeskim
pubmed-article:20881647pubmed:issue11lld:pubmed
pubmed-article:20881647pubmed:dateCreated2010-10-26lld:pubmed
pubmed-article:20881647pubmed:abstractText: Bevacizumab is approved in combination with chemotherapy as first-line treatment for non-small cell lung cancer (NSCLC). Preclinical data suggest that enzastaurin and bevacizumab may have complementary effects in inhibiting angiogenesis.lld:pubmed
pubmed-article:20881647pubmed:languageenglld:pubmed
pubmed-article:20881647pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:citationSubsetIMlld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20881647pubmed:statusMEDLINElld:pubmed
pubmed-article:20881647pubmed:monthNovlld:pubmed
pubmed-article:20881647pubmed:issn1556-1380lld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:HannaNasserNlld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:FisherWilliam...lld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:LiXiaochunXlld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:PatelJyotiJlld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:WuJingweiJlld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:BradfordDanie...lld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:BufillJoseJlld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:NattamSreeniv...lld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:LatzJane EJElld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:HarbWaelWlld:pubmed
pubmed-article:20881647pubmed:authorpubmed-author:CaseyErin MEMlld:pubmed
pubmed-article:20881647pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20881647pubmed:volume5lld:pubmed
pubmed-article:20881647pubmed:ownerNLMlld:pubmed
pubmed-article:20881647pubmed:authorsCompleteYlld:pubmed
pubmed-article:20881647pubmed:pagination1815-20lld:pubmed
pubmed-article:20881647pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:meshHeadingpubmed-meshheading:20881647...lld:pubmed
pubmed-article:20881647pubmed:year2010lld:pubmed
pubmed-article:20881647pubmed:articleTitleRandomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/IV non-small cell lung cancer: Hoosier Oncology Group LUN06-116.lld:pubmed
pubmed-article:20881647pubmed:affiliationIndiana University, Indianapolis, USA.lld:pubmed
pubmed-article:20881647pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20881647pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20881647pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20881647pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:20881647pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed